These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1649 related items for PubMed ID: 36451813
1. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C, Liu D, Wang F, Liu Y, Xie J, Xie J, Xie Y. Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [Abstract] [Full Text] [Related]
2. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma. Liu C, Liu D, Wang F, Xie J, Liu Y, Wang H, Rong J, Xie J, Wang J, Zeng R, Zhou F, Xie Y. Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794 [Abstract] [Full Text] [Related]
3. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma. Liu C, Liu D, Wang F, Xie J, Liu Y, Wang H, Rong J, Xie J, Wang J, Zeng R, Zhou F, Peng J, Xie Y. Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904 [Abstract] [Full Text] [Related]
9. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma. Liu X, Fang X, Lu L, Liu G. Front Genet; 2022; 13():996625. PubMed ID: 36568396 [Abstract] [Full Text] [Related]
10. A novel signature model based on mitochondrial-related genes for predicting survival of colon adenocarcinoma. Gao H, Xing F. BMC Med Inform Decis Mak; 2022 Oct 22; 22(1):277. PubMed ID: 36273131 [Abstract] [Full Text] [Related]
11. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma. Ouyang R, Li Z, Peng P, Zhang J, Liu J, Qin M, Huang J. Int J Med Sci; 2021 Oct 22; 18(3):685-694. PubMed ID: 33437203 [Abstract] [Full Text] [Related]
14. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma. Jia X, Zhang T, Lv X, Du H, Sun Y, Guan Y. Cancer Biomark; 2023 Oct 22; 38(4):523-535. PubMed ID: 38143338 [Abstract] [Full Text] [Related]
15. A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma. Cheng X, Wei Y, Fu Y, Li J, Han L. Front Immunol; 2022 Oct 22; 13():1052182. PubMed ID: 36532007 [Abstract] [Full Text] [Related]
17. Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3. Kong C, Zheng L, Fang S, Chen M, Lin G, Qiu R, Zhao Z, Chen W, Song J, Yang Y, Ji J. Technol Cancer Res Treat; 2023 Oct 22; 22():15330338231195494. PubMed ID: 37650153 [Abstract] [Full Text] [Related]
18. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma. Xu M, Mu J, Wang J, Zhou Q, Wang J. Front Oncol; 2022 Oct 22; 12():961213. PubMed ID: 35965536 [Abstract] [Full Text] [Related]
19. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J, Qin D, Tao Z, Wang B, Xie Y, Wang Y, Li B, Cao J, Qiao X, Zhong S, Hu X. Front Immunol; 2022 Oct 22; 13():1056932. PubMed ID: 36479114 [Abstract] [Full Text] [Related]
20. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma. Xiang J, Gong W, Liu J, Zhang H, Li M, Wang R, Lv Y, Sun P. Front Genet; 2023 Oct 22; 14():1098190. PubMed ID: 37274780 [Abstract] [Full Text] [Related] Page: [Next] [New Search]